Join the Zyvox group to help and get support from people like you.
Zyvox News
Shortened BDLC Regimen Not Noninferior for Drug-Resistant TB
TUESDAY, July 22, 2025 – For preextensively drug resistant tuberculosis (TB), a shortened bedaquiline, delamanid, linezolid, and clofazimine (BDLC) regimen is not noninferior to longer standard of...
Shorter Treatment Regimens Recommended for Tuberculosis
MONDAY, Jan. 13, 2025 – In a clinical practice guideline issued by the American Thoracic Society and published in the January issue of the American Journal of Respiratory and Critical Care Medicine,...
FDA Medwatch Alert: Linezolid Injection by Auromedics Pharma: Voluntary Recall 600mg/300mL flexible bags- Due to Presence White Particle Matter That Has Been Identified as Mold
ISSUE: AuroMedics Pharma is voluntarily recalling one lot of Linezolid Injection 600mg/300mL flexible bags, NDC 55150 -242 -51 batch CLZ160007 expiration August 2018 to the hospital level. This batch...
FDA Medwatch Alert: Zyvox (linezolid): Drug Safety Communication - Serious CNS Reactions Possible When Given to Patients Taking Certain Psychiatric Medications
ISSUE: FDA has received reports of serious central nervous system (CNS) reactions when the antibacterial drug linezolid (Zyvox) is given to patients taking psychiatric medications that work through...
FDA Medwatch Alert: Zyvox (linezolid)
[Posted 03/16/2007] FDA notified healthcare professionals of new emerging safety concerns about Zyvox (linezolid) from a recent clinical study. This open-label, randomized trial compared linezolid to...
Further information
Related condition support groups
Methicillin-Resistant Staphylococcus Aureus Infection, Bacterial Infection, Skin and Structure Infection, Pneumonia